Cardlytics (CDLX) Set to Announce Earnings on Wednesday

Cardlytics (NASDAQ:CDLX) is scheduled to post its quarterly earnings results after the market closes on Wednesday, May 8th. Cardlytics has set its Q1 2024 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) EPS for the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%. The business had revenue of $89.17 million for the quarter.

Cardlytics Price Performance

NASDAQ:CDLX opened at $14.88 on Monday. The business’s fifty day moving average is $12.07 and its 200 day moving average is $9.65. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 1.91. Cardlytics has a 52-week low of $4.94 and a 52-week high of $20.52.

Insider Buying and Selling

In other news, COO Amit Gupta sold 23,416 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total value of $278,884.56. Following the completion of the sale, the chief operating officer now owns 122,676 shares in the company, valued at approximately $1,461,071.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $13.69, for a total value of $170,577.40. Following the transaction, the insider now owns 71,355 shares in the company, valued at approximately $976,849.95. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Amit Gupta sold 23,416 shares of Cardlytics stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total value of $278,884.56. Following the transaction, the chief operating officer now owns 122,676 shares of the company’s stock, valued at $1,461,071.16. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 36,306 shares of company stock worth $455,203. Insiders own 4.40% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Lake Street Capital upped their target price on Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “buy” rating and raised their target price for the company from $10.00 to $18.00 in a research note on Friday, March 15th. Finally, Needham & Company LLC increased their target price on Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, April 9th.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.